BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33860559)

  • 1. Effect of anti-interleukin-17 biologics on Krebs von den Lungen-6 level in patients with psoriasis.
    Hara H; Miyagawa H; Araya J; Minagawa S; Numata T; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
    J Dermatol; 2021 Jun; 48(6):886-893. PubMed ID: 33860559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in Serum KL-6 Level during Biologic Treatment for Psoriasis.
    Hoashi T; Miyazaki S; Ozaki S; Ichiyama S; Ito M; Kanda N; Saeki H
    J Nippon Med Sch; 2023; 90(2):194-201. PubMed ID: 37258257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
    Iwata H; Haga N; Sugai T; Fujita Y
    J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.
    Miyagawa H; Hara H; Araya J; Minagawa S; Numata T; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
    PLoS One; 2021; 16(1):e0245284. PubMed ID: 33411857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial Pneumonia in Psoriasis.
    Kawamoto H; Hara H; Minagawa S; Numata T; Araya J; Kaneko Y; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
    Mayo Clin Proc Innov Qual Outcomes; 2018 Dec; 2(4):370-377. PubMed ID: 30560239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositis.
    Isoda K; Kotani T; Takeuchi T; Konma J; Ishida T; Hata K; Otani K; Fujiwara H; Shoda T; Makino S; Arawaka S
    Clin Respir J; 2018 Jul; 12(7):2235-2241. PubMed ID: 29633527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krebs von den Lungen-6 as a Potential Predictive Biomarker in Fibrosing Interstitial Lung Diseases.
    Lederer C; Mayer K; Somogyi V; Kriegsmann K; Kriegsmann M; Buschulte K; Polke M; Findeisen P; Herth F; Kreuter M
    Respiration; 2023; 102(8):591-600. PubMed ID: 37586349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 level.
    Chijiwa C; Takeoka S; Kamata M; Uchida H; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    Br J Dermatol; 2018 Dec; 179(6):1396-1397. PubMed ID: 29985537
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases.
    Cho EJ; Park KJ; Ko DH; Koo HJ; Lee SM; Song JW; Lee W; Lee HK; Do KH; Chun S; Min WK
    Ann Lab Med; 2019 May; 39(3):245-251. PubMed ID: 30623616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical Analysis of Krebs von den Lungen-6 (KL-6) Expression in Lung Tissue in Primary Lung Cancer Patients with High Serum KL-6 Levels].
    Yatsuyanagi E; Sato K; Sato K
    Kyobu Geka; 2015 Sep; 68(10):815-9. PubMed ID: 26329623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor-α therapy.
    Higashi Y; Tada K; Shimokawa M; Kawai K; Kanekura T
    Clin Exp Dermatol; 2016 Jan; 41(1):88-90. PubMed ID: 25557847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Kohno N; Hattori N
    Medicine (Baltimore); 2018 Dec; 97(49):e13542. PubMed ID: 30544464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia.
    Fukuhara N; Tanino Y; Sato S; Fukuhara A; Uematsu M; Nikaido T; Misa K; Sato Y; Saito J; Wang X; Munakata M
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):265-70. PubMed ID: 26422573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumonia.
    Letellier A; Rolland-Debord C; Luque-Paz D; Milon A; Choinier P; Blin E; Halitim P; Bravais J; Lefèvre G; Parrot A; Piéroni L; Cadranel J
    Respir Med Res; 2023 Nov; 84():101054. PubMed ID: 37897878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy.
    Yamashita H; Kobayashi-Shibata S; Terahara A; Okuma K; Haga A; Wakui R; Ohtomo K; Nakagawa K
    Radiat Oncol; 2010 May; 5():32. PubMed ID: 20459699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia.
    Lee YS; Kim HC; Lee BY; Lee CK; Kim MY; Jang SJ; Lee HS; Moon J; Colby TV; Kim DS
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):216-223. PubMed ID: 27758986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease.
    Ko UW; Cho EJ; Oh HB; Koo HJ; Do KH; Song JW
    PLoS One; 2020; 15(12):e0244114. PubMed ID: 33332430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.